Skip to content
Solve-RD

Solve-RD

Solving the Unsolved Rare Diseases

  • Twitter
  • Welcome
  • The Project
    • WP 1: Unique RD patients and phenotypes
    • WP 2: Novel molecular causes
    • WP 3: Changing patient lives: Translation to the clinic
      • The Treatabolome
    • WP 4: Bioinformatics and knowledge management
    • WP 5: Engagement and impact
      • Community Engagement Task Force
    • WP 6: Coordination and innovation management
    • WP 7: Ethics requirements
  • The Group
    • Consortium
      • EKUT – 1a
      • EKUT – 1b
      • RUMC – 2
      • ULEIC – 3
      • UNEW – 4
      • MUH – 5
      • CHU Dijon – 6a
      • UB – 6b
      • CNAG-CRG – 7
      • EURORDIS – 8
      • INSERM-Orphanet – 9a
      • INSERM-ICM – 9b
      • INSERM-CRM – 9c
      • CUP – 10
      • EMBL-EBI – 11
      • JAX – 12
      • KCL – 13
      • UCL-IoN – 14a
      • UCL-ICH – 14b
      • UA – 15
      • Uni Naples – 16
      • UNIFE – 17
      • UHB – 18
      • IPATIMUP – 19
      • UMCG – 20
      • Charité -21
      • SHU – 22
      • APHP – 23
    • Project Coordinator
    • Project Office
    • Steering Committee
    • Scientific Advisory Board
    • Independent Ethics Advisory Board
    • Data Analysis Task Force (DATF)
    • Data Interpretation Task Force (DITF)
    • Associated European Reference Networks
    • Collaborations
  • Platforms & Tools
    • Rare Diseases Models & Mechanisms
      • For Clinicians
      • For Model Organism Investigators
      • Registry
      • RDMM Committees
      • Funded projects
      • FAQ
  • Results
    • Solve-RD data
    • Scientific publications
    • Deliverables & reports
    • Other documents
  • Meetings
    • Next Meetings
    • Past Meetings
  • News
  • Twitter

Solve-RD WP4 meeting

June 20 2018, Amsterdam, the Netherlands

Author AdminPosted on June 20, 2018June 23, 2018Categories Meeting

Post navigation

Previous Previous post: Solve-RD kick-off meeting 2018
Next Next post: Solve-RD Steering Committee meeting
Flag of Europe

The Solve-RD project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 779257.

Contact | Imprint & Disclaimer

  • Twitter
We serve cookies on this site to to analyse traffic, remember your preferences, optimise your experience and to implement our Twitter Feed.OKNo 3rd party cookiesData-Protection